All stock lists
American Well Corp (New York Stock Exchange:AMWL)
US · Delayed Price · Currency is USD
Healthcare · Medical - Healthcare Information Services
13.57-0.62 (-4.37%)
Insider Score
––Not scored
AMWL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AMWL analyst forecast
AMWL analyst consensus
Hold2 ratings
Buy 0 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AMWL 12-month price target
No published price targets in the last 12 months.
Best analysts covering AMWL
- Wells Fargo50%success rate · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AMWL analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Truist Securities | Hold | — | — | Reiterated | 2026-08-13 |
| — | Needham | Hold | — | — | Reiterated | 2026-08-05 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-17 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-05-06 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-05-06 |
| — | Stifel | Hold | — | — | Reiterated | 2026-02-13 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-12-18 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-11-05 |
| — | Stifel | Hold | — | — | Reiterated | 2025-11-05 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2025-08-07 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2025-05-23 |
| — | UBS | Neutral | — | — | Reiterated | 2025-05-08 |
| — | Stifel | Hold | — | — | Reiterated | 2025-05-02 |
| — | Needham | Hold | — | — | Reiterated | 2025-05-02 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-04-10 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-02-14 |
| — | Needham | Hold | — | — | Reiterated | 2025-02-13 |
| — | Stifel | Hold | — | — | Reiterated | 2025-02-13 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2025-01-13 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2024-12-17 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2024-08-06 |
| — | UBS | Neutral | — | — | Reiterated | 2024-05-23 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2024-04-15 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2023-11-02 |
| — | Morgan Stanley | Equal Weight | — | — | Downgraded | 2023-08-03 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2023-05-04 |
| — | TD Cowen | Market Perform | — | — | Downgraded | 2023-03-23 |
| — | Guggenheim | Buy | — | — | Reiterated | 2023-03-15 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-03-13 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2023-02-27 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2023-02-23 |
| — | Needham | Hold | — | — | Reiterated | 2023-02-23 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-01-06 |
| — | B of A Securities | Buy | — | — | Upgraded | 2023-01-04 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2022-09-07 |
| — | Truist Securities | Hold | — | — | Reiterated | 2022-09-07 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2022-06-23 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2022-05-17 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2022-05-10 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2022-02-28 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2021-12-17 |
| — | Jefferies | Hold | — | — | Reiterated | 2021-12-02 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2021-11-11 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2021-09-14 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2021-08-31 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2021-08-24 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2021-08-12 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2021-07-02 |
| — | Guggenheim | Buy | — | — | Upgraded | 2021-05-17 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2021-05-13 |
| — | Keybanc | Equal Weight | — | — | Reiterated | 2021-04-16 |
| — | Needham | Hold | — | — | Reiterated | 2021-04-15 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2021-03-26 |
| — | Credit Suisse | Neutral | — | — | Downgraded | 2021-01-28 |
AMWL earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-12 | -1.59 | -1.43 | $52.6M | $55.3M |
| 2026-05-05 | -0.77 | -0.66 | $51.5M | $54.9M |
| 2026-08-04 | -0.86 | -0.59 | $49.9M | $52.0M |
| 2026-11-03 | -0.66 | 0.00 | $47.3M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.